TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medipal Holdings ( (JP:7459) ) just unveiled an update.
Medipal Holdings Corporation has announced a change in its leadership structure due to the medical treatment of its current President and CEO, Shuichi Watanabe. Yasuhiro Choufuku, currently serving as Director and Vice President, has been appointed as an additional representative director and will act on behalf of the president, ensuring continuity in leadership and operations.
The most recent analyst rating on (JP:7459) stock is a Hold with a Yen2620.00 price target. To see the full list of analyst forecasts on Medipal Holdings stock, see the JP:7459 Stock Forecast page.
More about Medipal Holdings
Medipal Holdings Corporation operates in the pharmaceutical industry, focusing on the distribution and management of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and has a significant presence in the Japanese market.
Average Trading Volume: 407,569
Technical Sentiment Signal: Hold
Current Market Cap: Yen415.9B
See more insights into 7459 stock on TipRanks’ Stock Analysis page.